These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37708991)

  • 1. Charge variants of proposed biosimilar to Omalizumab: Isolation, purification and analysis by HPLC methods.
    Gupta T; Seshadri S
    Ann Pharm Fr; 2024 Jan; 82(1):64-71. PubMed ID: 37708991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly purified charge variants of a proposed biosimilar to Omalizumab: impact on in vitro potency and stability under thermal stress.
    Gupta T; Seshadri S
    Bioprocess Biosyst Eng; 2024 Jan; 47(1):57-64. PubMed ID: 38156991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analytical assays for the characterization of drugs binding to human IgE: Applicability to omalizumab-bearing biosimilar candidates assessment.
    Urbano A; Plaza J; Picado C; de Mora F
    Biomed Pharmacother; 2023 Dec; 169():115848. PubMed ID: 37976893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat.
    Zhao YY; Wang N; Liu WH; Tao WJ; Liu LL; Shen ZD
    PLoS One; 2016; 11(3):e0151874. PubMed ID: 26987122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Structural characterization and analysis of Omalizumab and its biosimilar CMAB007 by LC-MS].
    Xu J; Zhang D; Wang H; Guo H
    Sheng Wu Gong Cheng Xue Bao; 2016 Apr; 32(4):497-506. PubMed ID: 28853271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab.
    Visser J; Feuerstein I; Stangler T; Schmiederer T; Fritsch C; Schiestl M
    BioDrugs; 2013 Oct; 27(5):495-507. PubMed ID: 23649935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital twin of a continuous chromatography process for mAb purification: Design and model-based control.
    Tiwari A; Masampally VS; Agarwal A; Rathore AS
    Biotechnol Bioeng; 2023 Mar; 120(3):748-766. PubMed ID: 36517960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical and Biological Characterization of RTXM83, a New Rituximab Biosimilar.
    Cerutti ML; Pesce A; Bès C; Seigelchifer M
    BioDrugs; 2019 Jun; 33(3):307-319. PubMed ID: 30927214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization.
    Ruppen I; Beydon ME; Solís C; Sacristán D; Vandenheede I; Ortiz A; Sandra K; Adhikary L
    Biologicals; 2022 Jun; 77():1-15. PubMed ID: 35667958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization.
    Ruppen I; Beydon ME; Solís C; Sacristán D; Vandenheede I; Ortiz A; Sandra K; Adhikary L
    Biologicals; 2021 Sep; 73():41-56. PubMed ID: 34593306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charge variant analysis of proposed biosimilar to Trastuzumab.
    Dakshinamurthy P; Mukunda P; Prasad Kodaganti B; Shenoy BR; Natarajan B; Maliwalave A; Halan V; Murugesan S; Maity S
    Biologicals; 2017 Mar; 46():46-56. PubMed ID: 28087106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of charge variants of infliximab biosimilar HS626.
    Yuan JJ; Gao D; Hu F; Shi Y; Wu ZH; Hu CQ; Huang XD; Fang WJ; Zhang HT; Wang HB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122485. PubMed ID: 33360415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin
    Gurel B; Berksoz M; Capkin E; Parlar A; Pala MC; Ozkan A; Capan Y; Daglikoca DE; Yuce M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgE, allergic diseases, and omalizumab.
    DuBuske LM
    Curr Pharm Des; 2006; 12(30):3929-44. PubMed ID: 17073688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion exchange chromatography hyphenated with fluorescence detector as a sensitive alternative to UV detector: Applications in biopharmaceutical analysis.
    Joshi S; Upadhyay K; S Rathore A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Dec; 1212():123511. PubMed ID: 36334329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of IgE Antibodies to Omalizumab (Xolair®) and Their Potential Correlation to Anaphylaxis.
    Baker DL; Nakamura GR; Lowman HB; Fischer SK
    AAPS J; 2016 Jan; 18(1):115-23. PubMed ID: 26340860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using continuous chromatography methodology to achieve high-productivity and high-purity enrichment of charge variants for analytical characterization.
    Bigelow E; Song Y; Chen J; Holstein M; Huang Y; Duhamel L; Stone K; Furman R; Li ZJ; Ghose S
    J Chromatogr A; 2021 Apr; 1643():462008. PubMed ID: 33780880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Online Two-Dimensional Approach to Characterizing the Charge-Based Heterogeneity of Recombinant Monoclonal Antibodies Using a 2D-CEX-AEX-MS Workflow.
    Kumar S; Peruri V; Rathore AS
    J Am Soc Mass Spectrom; 2023 Dec; 34(12):2801-2810. PubMed ID: 37994779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.